The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer

2018/04/05 by Tuo Li, Zhijian J. Chen · 1,291 citations
Immunology and Microbiology · Medicine · #Biology #Cell biology #DNA #DNA damage #Genetics #Genome instability #Guanosine #Immune Response and Inflammation #Immune system #Immunology #Inflammation #Innate immune system #Senescence #Signal transducing adaptor protein #Signal transduction #Stimulator of interferon genes #Viral Infections and Vectors #interferon and immune responses

paper · pdf · doi:10.1084/jem.20180139

published in The Journal of Experimental Medicine 215(5), 1287-1299 (Rockefeller University Press)

openalex publication_date 2018/04/05 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05

Abstract

Detection of microbial DNA is an evolutionarily conserved mechanism that alerts the host immune system to mount a defense response to microbial infections. However, this detection mechanism also poses a challenge to the host as to how to distinguish foreign DNA from abundant self-DNA. Cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase (cGAS) is a DNA sensor that triggers innate immune responses through production of the second messenger cyclic GMP-AMP (cGAMP), which binds and activates the adaptor protein STING. However, cGAS can be activated by double-stranded DNA irrespective of the sequence, including self-DNA. Although how cGAS is normally kept inactive in cells is still not well understood, recent research has provided strong evidence that genomic DNA damage leads to cGAS activation to stimulate inflammatory responses. This review summarizes recent findings on how genomic instability and DNA damage trigger cGAS activation and how cGAS serves as a link from DNA damage to inflammation, cellular senescence, and cancer.

Cited by

• The Epigenetic Hallmarks of Cancer
• Redox signaling in cell fate: Beyond damage
• Identification of Uncharacterized Components of Prokaryotic Immune Systems and Their Diverse Eukaryotic Reformulations
• Turning Cold into Hot: Firing up the Tumor Microenvironment
• Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy
• Molecular mechanisms regulating cGAS/STING activation in health and disease
• The interferon paradox in actinic keratosis
• The paradoxical role of radiation‐induced cGAS–STING signalling network in tumour immunity
• Molecular mechanisms and cellular functions of cGAS–STING signalling
• Photoaging: UV radiation-induced inflammation and immunosuppression accelerate the aging process in the skin
• SAMHD1 in cancer: curse or cure?
• Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging
• PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. [europepmc]
• The Ca 2+ sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum. [europepmc]
• Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer. [europepmc]
• Structural basis of STING binding with and phosphorylation by TBK1. [europepmc]
• Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP. [europepmc]
• LINE1 Derepression in Aged Wild-Type and SIRT6-Deficient Mice Drives Inflammation. [europepmc]
• Phagocytosis checkpoints as new targets for cancer immunotherapy. [europepmc]
• SLC19A1 transports immunoreactive cyclic dinucleotides. [europepmc]
• Tight nuclear tethering of cGAS is essential for preventing autoreactivity. [europepmc]
• Enhancing cancer immunotherapy with nanomedicine. [europepmc]
• DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. [europepmc]
• Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. [europepmc]
• Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma. [europepmc]
• PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance. [europepmc]
• An update on the regulatory mechanisms of NLRP3 inflammasome activation. [europepmc]
• Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype. [europepmc]
• Ferroptosis in infection, inflammation, and immunity. [europepmc]
• Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention. [europepmc]
• NAD + supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING. [europepmc]
• Reactive Oxygen Species in Macrophages: Sources and Targets. [europepmc]
• Strategies for Targeting Senescent Cells in Human Disease. [europepmc]
• Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy. [europepmc]
• DNA damage and repair in age-related inflammation. [europepmc]
• Inflammation and aging: signaling pathways and intervention therapies. [europepmc]
• Chronic inflammation and the hallmarks of aging. [europepmc]

Related

• Regulation of the cGAS-STING Pathway
• cGAS‐STING signaling in cell death: Mechanisms of action and implications in pathologies
• DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS–STING signalling
• Molecular mechanisms regulating cGAS/STING activation in health and disease
• A noncanonical cGAS–STING pathway drives cellular and organismal aging